EUR 2.22
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 3 Million EUR | 8.54% |
2022 | 2.76 Million EUR | 108.62% |
2021 | 1.32 Million EUR | -32.11% |
2020 | 1.95 Million EUR | -13.09% |
2019 | 2.24 Million EUR | 65.53% |
2018 | 1.35 Million EUR | 23.41% |
2017 | 1.09 Million EUR | -67.18% |
2016 | 3.35 Million EUR | 75.34% |
2015 | 1.91 Million EUR | -34.6% |
2014 | 2.92 Million EUR | -0.49% |
2013 | 2.93 Million EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 643.27 Thousand EUR | -27.7% |
2024 Q2 | 643.27 Thousand EUR | 0.0% |
2023 Q1 | 602.64 Thousand EUR | -54.46% |
2023 Q4 | 889.71 Thousand EUR | 0.82% |
2023 FY | 2.65 Million EUR | -4.16% |
2023 Q2 | 1.06 Million EUR | 76.08% |
2023 Q3 | 882.48 Thousand EUR | -16.83% |
2022 Q1 | 743.45 Thousand EUR | -7.93% |
2022 FY | 2.76 Million EUR | 108.62% |
2022 Q4 | 1.32 Million EUR | 98.61% |
2022 Q3 | 666.23 Thousand EUR | -53.21% |
2022 Q2 | 1.42 Million EUR | 91.54% |
2021 Q2 | 518.1 Thousand EUR | 85.27% |
2021 Q4 | 807.45 Thousand EUR | 97.22% |
2021 Q1 | 279.64 Thousand EUR | -76.33% |
2021 Q3 | 409.41 Thousand EUR | -20.98% |
2021 FY | 1.32 Million EUR | -32.11% |
2020 Q2 | 761.29 Thousand EUR | 94.35% |
2020 FY | 1.95 Million EUR | -13.09% |
2020 Q1 | 391.7 Thousand EUR | -67.14% |
2020 Q3 | 610.4 Thousand EUR | -19.82% |
2020 Q4 | 1.18 Million EUR | 93.52% |
2019 Q2 | 1.05 Million EUR | 95.6% |
2019 Q4 | 1.19 Million EUR | 95.54% |
2019 FY | 2.24 Million EUR | 65.53% |
2019 Q1 | 539.06 Thousand EUR | 35.4% |
2019 Q3 | 609.7 Thousand EUR | -42.18% |
2018 FY | 1.35 Million EUR | 23.41% |
2018 Q4 | 398.11 Thousand EUR | 0.0% |
2018 Q3 | 398.11 Thousand EUR | 28.29% |
2018 Q2 | 310.31 Thousand EUR | 0.0% |
2018 Q1 | 310.31 Thousand EUR | 173.57% |
2017 Q1 | 426.36 Thousand EUR | -51.34% |
2017 Q2 | 426.36 Thousand EUR | -0.0% |
2017 FY | 1.09 Million EUR | -67.18% |
2017 Q4 | 113.43 Thousand EUR | 0.0% |
2017 Q3 | 113.43 Thousand EUR | -73.4% |
2016 Q1 | 800.66 Thousand EUR | 108.5% |
2016 Q3 | 876.24 Thousand EUR | 9.44% |
2016 Q4 | 876.24 Thousand EUR | 0.0% |
2016 FY | 3.35 Million EUR | 75.34% |
2016 Q2 | 800.66 Thousand EUR | 0.0% |
2015 Q1 | 754.54 Thousand EUR | -21.17% |
2015 Q4 | 384.01 Thousand EUR | 11.18% |
2015 Q3 | 345.4 Thousand EUR | -25.84% |
2015 Q2 | 465.74 Thousand EUR | -38.27% |
2015 FY | 1.91 Million EUR | -34.6% |
2014 Q2 | 452.22 Thousand EUR | -28.27% |
2014 Q3 | 852.96 Thousand EUR | 88.62% |
2014 Q4 | 957.24 Thousand EUR | 12.22% |
2014 FY | 2.92 Million EUR | -0.49% |
2014 Q1 | 630.48 Thousand EUR | -27.1% |
2013 Q3 | 817.01 Thousand EUR | 14.97% |
2013 Q2 | 710.6 Thousand EUR | 24.9% |
2013 Q4 | 864.87 Thousand EUR | 5.86% |
2013 FY | 2.93 Million EUR | 0.0% |
2013 Q1 | 568.96 Thousand EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Evrofarma SA | 3.65 Million EUR | 17.881% |
Kri-Kri Milk Industry S.A. | 39.21 Million EUR | 92.345% |
Loulis Food Ingredients S.A. | 7.49 Million EUR | 59.979% |